Amazon Announced 2nd Deals Event For 2022 As Customers Face ‘Macroeconomic’ Challenges
Amazon.com Inc. (NASDAQ: AMZN) has announced a new holiday shopping event — Prime Early Access Sale — for its members.
Will Google’s Pixel Watch End Apple Watch’s Dominance?
Alphabet Inc.'s (NASDAQ: GOOG) (NASDAQ: GOOGL) Google recently confirmed the existence of its long-rumored Pixel Watch — its take on Apple Inc.'s (NASDAQ:
Watch Out! This Activist Investor May Put Pressure On These 3 High-Yielding Stocks
Trian Partners was founded in 2005 by activist investor Nelson Peltz, who has a history of buying up shares, securing board seats and orchestrating M&A deals.
Belite Bio Announces Late-Breaking Presentation At The American Academy Of Ophthalmology 2022 Annual Meeting
Belite Bio, Inc (NASDAQ:BLTE), a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, today announced that the 1-year interim data from the 2-year Phase
Qualcomm Partners With Mercedes-Benz, Red Hat On Automotive Tech: What Investors Need To Know
Qualcomm Inc (NASDAQ: QCOM) unveiled partnerships with top manufacturers to propel the development of the next generation of connected vehicles Thursday at its Automotive Investor Day.
Qualcomm Automotive Investor Day To Begin At 3:00 p.m. ET
https://www.youtube.com/watch?v=HKii6W38sW4
‘I’ll Be SMOKIN’! WOOOOO!’ – Ric Flair And Mike Tyson Share A Blunt In The Middle Of A Business Conference
Mike Tyson and Ric Flair are both renowned for their unique style and approach within their respective sports.
Nvidia Makes A ‘Quantum Leap’ At GTC 2022: Ada Lovelace RTX GPUs, Omniverse Cloud, DRIVE Thor Superchip For Autonomous Vehicles
NVIDIA Corp's (NASDAQ: NVDA) GPU Technology Conference (GTC) was packed with company updates, led by the launch of a new generation of GeForce RTX GPUs. Here's a look at some highlights from the event.
VBI Vaccines Announces Presentation Of Physician-Initiated Compassionate Use Data Of 3-Antigen Hepatitis B Vaccine At 2022 International HBV Meeting; Presentation Was Monday, Sept. 19
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that data from the physician-initiated